David B. Reitz

Pyrrolopyridine Inhibitors of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK-2)

David R. Anderson, Marvin J. Meyers, William F. Vernier et al. · Journal of Medicinal Chemistry · 2007 · 169 citations · Full text

Novel tetrahydro-β-carboline-1-carboxylic acids as inhibitors of mitogen activated protein kinase-activated protein kinase 2 (MK-2)

John I. Trujillo, Marvin J. Meyers, David R. Anderson et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 136 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Pharmaceutical Chemistry +10

Selective Cyclooxygenase Inhibitors: Novel 1,2-Diarylcyclopentenes Are Potent and Orally Active COX-2 Inhibitors

David B. Reitz, James J. Li, Monica B. Norton et al. · Journal of Medicinal Chemistry · 1994 · 118 citations · Full text

Altmetric Attention Score, Pharmacotherapy, Pre-clinical Pharmacology +19

Novel Terphenyls as Selective Cyclooxygenase-2 Inhibitors and Orally Active Anti-inflammatory Agents

James J. Li, Monica B. Norton, Emily J. Reinhard et al. · Journal of Medicinal Chemistry · 1996 · 106 citations · Full text

Terphenyl Methyl Sulfones, Pharmaceutical Science, Pharmacotherapy +17

Discovery of (3<i>S</i>,3a<i>R</i>)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2<i>H</i>-benzo[<i>g</i>]indazole-7-carboxylic Acid (PF-3882845), an Orally Efficacious Mineralocorticoid Receptor (MR) Antagonist for Hypertension and Nephropathy

Marvin J. Meyers, Graciela B. Arhancet, Susan L. Hockerman et al. · Journal of Medicinal Chemistry · 2010 · 91 citations · Full text

Excellent Potency, Exquisite Potency, Renal Inflammation +19